Mostrar el registro sencillo del ítem

dc.contributor.authorNi, L.
dc.contributor.authorLiu, L.
dc.contributor.authorZhu, W.
dc.contributor.authorTelljohann, R.
dc.contributor.authorZhang, J.
dc.contributor.authorMonticone, R.E.
dc.contributor.authorMcGraw, K.R.
dc.contributor.authorLiu, C.
dc.contributor.authorMorrell, C.H.
dc.contributor.authorGarrido Gil, Pablo
dc.contributor.authorLabandeira García, José Luis
dc.contributor.authorLakatta, E.G.
dc.contributor.authorWang, M.
dc.date.accessioned2025-08-26T09:27:12Z
dc.date.available2025-08-26T09:27:12Z
dc.date.issued2022
dc.identifier.citationNi L, Liu L, Zhu W, Telljohann R, Zhang J, Monticone RE, et al. Inflammatory Role of Milk Fat Globule- Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling. Journal of the American Heart Association. 2022;11(17).
dc.identifier.issn2047-9980
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/632656cfd50fae52cd31b517*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20652
dc.description.abstractBACKGROUND: Age-associated aortic remodeling includes a marked increase in intimal medial thickness (IMT), associated with signs of inflammation. Although aortic wall milk fat globule- epidermal growth factor VIII (MFG-E8) increases with age, and is associated with aortic inflammation, it is not known whether MFG-E8 is required for the age-associated increase in aortic IMT. Here, we tested whether MFG-E8 is required for the age-associated increase in aortic IMT. METHODS AND RESULTS: To determine the role of MFG-E8 in the age-associated increase of IMT, we compared aortic remodeling in adult (20-week) and aged (96-week) MFG-E8 (?/?) knockout and age matched wild-type (WT) littermate mice. The average aortic IMT increased with age in the WT from 50±10 to 70±20 ?m (P<0.0001) but did not significantly increase with age in MFG-E8 knockout mice. Because angiotensin II signaling is implicated as a driver of age-associated increase in IMT, we infused 30-week-old MFG-E8 knockout and age-matched littermate WT mice with angiotensin II or saline via osmotic minipumps to determine whether MFG-E8 is required for angiotensin II- induced aortic remodeling. (1) In WT mice, angiotensin II infusion substantially increased IMT, elastic lamina degradation, collagen deposition, and the proliferation of vascular smooth muscle cells; in contrast, these effects were significantly reduced in MFG-E8 KO mice; (2) On a molecular level, angiotensin II treatment significantly increased the activation and expression of matrix metalloproteinase type 2, transforming growth factor beta 1, and its downstream signaling molecule phosphorylated mother against decapentaplegic homolog 2, and collagen type I production in WT mice; however, in the MFG-E8 knockout mice, these molecular effects were significantly reduced; and (3) in WT mice, angiotensin II increased the levels of aortic inflammatory markers phosphorylated nuclear factor-kappa beta p65, monocyte chemoattractant protein 1, tumor necrosis factor alpha, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 molecular expression, while in contrast, these inflammatory markers did not change in knockout mice. CONCLUSIONS: Thus, MFG-E8 is required for both age-associated proinflammatory aortic remodeling and also for the angiotensin II- dependent induction in younger mice of an aortic inflammatory phenotype observed in advanced age. Targeting MFG-E8 would be a novel molecular approach to curb adverse arterial remodeling.en
dc.description.sponsorshipThis research was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, the National Natural Science Foundation of China (No. 81470585) and the Fundamental Research Funds for the Central Universities (No. 3332019028).en
dc.language.isoeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleInflammatory Role of Milk Fat Globule- Epidermal Growth Factor VIII in Age-Associated Arterial Remodeling*
dc.typeArticleen
dc.authorsophosNi, M. L.
dc.authorsophosLiu, L.
dc.authorsophosZhu, W.
dc.authorsophosTelljohann, R.
dc.authorsophosZhang, J.
dc.authorsophosMonticone, R. E.
dc.authorsophosMcGraw, K. R.
dc.authorsophosLiu, C.
dc.authorsophosMorrell, C. H.
dc.authorsophosGarrido-Gil, P.
dc.authorsophosLabandeira-Garcia, J. L.
dc.authorsophosLakatta, E. G.
dc.authorsophosWang
dc.identifier.doi10.1161/jaha.121.022574
dc.identifier.sophos632656cfd50fae52cd31b517
dc.issue.number17
dc.journal.titleJournal of the American Heart Association*
dc.relation.projectIDIntramural Research Program of the National Institute on Aging, National Institutes of Health; National Natural Science Foundation of China [81470585]; Fundamental Research Funds for the Central Universities [3332019028]
dc.relation.publisherversionhttps://www.ahajournals.org/doi/pdf/10.1161/JAHA.121.022574;https://www.ahajournals.org/doi/pdf/10.1161/JAHA.121.022574?download=truees
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Santiagoes
dc.subject.keywordIDISes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number11


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International